AMERICANA RESTAURANTS INTERNATIONAL-

Restaurant giant Americana Restaurants International saw its bottom line grow 19.8% y-o-y in 1Q 2025, reaching USD 31.9 mn, according to its financials (pdf). The company’s revenues also surged by 16.2% y-o-y to USD 573.4 mn in 1Q.

Americana’s growth was mainly fueled by higher sales and the company’s expansion of its store footprint, which now totals 2.6k outlets across 12 countries, according to a separate earnings release (pdf). The company’s growth in net income attributable to the parent company shareholders, up 16.5% y-o-y to USD 32.6 mn, was supported by its strong topline and improved gross margins through cost-cutting measures.

ALSO- The company’s shareholders approved a USD 127 mn dividend distribution at some USD 0.015 per share for FY 2024, according to a Tadawul filing (pdf). The distribution date will be announced later.

MODERN MILLS-

Modern Mills’ net income inched up 1% y-o-y to SAR 65.6 mn in 1Q 2025, on the back of lower finance costs and a modest revenue growth, it said in a disclosure to Tadawul. Higher bran supply for feed supported a 0.8% y-o-y revenue growth to SAR 259.9 mn despite lower feed sales.

SUMOU REAL ESTATE-

Sumou Real Estate reported a 17% y-o-y rise in net income in 1Q 2025 to SAR 22.4 mn, it said in a disclosure to Tadawul. The developer’s revenue also was up 25.3% y-o-y to SAR 101.5 mn over the same period.

BASIC CHEMICAL INDUSTRIES-

Basic Chemical Industries saw its net income plummet 72.3% y-o-y to SAR 2.9 mn in 1Q 2025, according to a disclosure to Tadawul, due to lower average selling prices and increasing zakat and tax expenses. Revenue dipped 10.1% y-o-y to SAR 161.6 mn, pulled down by a drop in chemicals sales including industrial, toll manufacturing and water treatment chemicals as well as polymers and adhesives.

RASAN IT-

Ins. provider Rasan IT, saw its net income jump 216.7% y-o-y to SAR 30 mn in 1Q 2025, it said in a disclosure to Tadawul. Revenue rose 80% y-o-y to SAR 120.5 mn, backed by growth in policy sales and clients, the rollout of additional business lines and distribution channels, and cross-selling and upselling initiatives.

JAMJOOM PHARMACEUTICALS-

Jeddah-based Jamjoom Pharmaceuticals Factory’s net income rose 52.5% y-o-y to SAR 157 mn in 1Q 2025, driven by a drop in finance costs, as well as income from its Algerian JV, it said in an earnings release (pdf). Revenue was up 18.7% y-o-y to SAR 457.5 mn, backed by higher production in both GCC and Egypt-based facilities, as well as strong performance across “key therapeutic areas.”

Tags: